Xilio Therapeutics XLO
NASDAQ XLO
$8.47 -0.06 (-0.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Xilio Therapeutics (XLO) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Analysis

Xilio Therapeutics (XLO) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Xilio Therapeutics 167.94 Mn -378.15 Mn - 134.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 134.83 Mn
Jun 30, 2026 154.25 Mn
Mar 31, 2026 163.49 Mn
Dec 31, 2025 154.69 Mn
Sep 30, 2025 133.69 Mn
Jun 30, 2025 133.81 Mn
Mar 31, 2025 103.72 Mn
Dec 31, 2024 71.08 Mn
Sep 30, 2024 74.66 Mn
Jun 30, 2024 89.87 Mn
Mar 31, 2024 82.61 Mn
Dec 31, 2023 60.93 Mn
Sep 30, 2023 77.84 Mn
Jun 30, 2023 92.36 Mn
Mar 31, 2023 111.51 Mn
Dec 31, 2022 139.17 Mn
Sep 30, 2022 157.41 Mn
Jun 30, 2022 178.13 Mn
Mar 31, 2022 196.35 Mn
Dec 31, 2021 218.06 Mn
API Access

Xilio Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=XLO&period=max&api_key=YOUR_API_KEY